Market Tracker

01/20 5:16pm ET

Vanguard Health Care Index Fund ETF Shares (VHT)

129.02
Delayed Data
As of Jan 20
 -0.29 / -0.22%
Today’s Change
113.02
Today|||52-Week Range
138.99
+1.77%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

ETFs in Focus on Robust Q4 UnitedHealth Earnings
Jan 18 / Zacks.com - Paid Partner Content
Why Novartis Dropped 15.1% in 2016
Jan 11 / MotleyFool.com - Paid Partner Content

Performance

1 month+1.13% 3 years+8.41%
3 months+0.34% 5 years+16.73%
1 year+7.27% Since inception+8.95%
Data through 01/21/2017

Quote Details

Previous close$129.31
Open day’s range128.84 – 129.87
Net asset value (NAV)128.99 (01/20/2017)
Daily volume204,788
Average volume (3 months)275,543
Data as of 7:59pm ET, 01/20/2017

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+16.73%+16.84%
Expense Gross exp ratio0.10%1.32%
Risk 5 year sharpe ratio1.321.08
Net assets$6.2B$2.8B
Average market cap$48.1B$32.0B
Average P/E21.619.5
Dividend / Share--0.32%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.22%
PFE Pfizer6.39%
MRK Merck5.28%
UNH UnitedHealth4.94%
AMGN Amgen3.55%
ABBV AbbVie3.31%
MDT Medtronic PLC3.22%
BMY Bristol-Myers Squibb3.16%
GILD Gilead Sciences3.06%
CELG Celgene2.91%